Document:

EX-10.50

 Exhibit 10.50 

CONFORMED COPY 
 WEBMD
HEALTH CORP. 
 PERFORMANCE-BASED RESTRICTED STOCK AGREEMENT 

THIS PERFORMANCE-BASED RESTRICTED STOCK AGREEMENT is made effective as of November 2, 2016 (the “Grant
Date”), by and between WebMD Health Corp., a Delaware corporation (the “Company”), and Steven L. Zatz (the “Holder”): 

WHEREAS, the Compensation Committee of the Company’s Board of Directors has determined that it would be to the advantage and in the
best interest of the Company and its stockholders to enter into this Performance-Based Restricted Stock Agreement (the “Agreement”) pursuant to the Company’s Amended and Restated 2005 Long-Term Incentive Plan, (the
“Plan”; all capitalized terms used herein without definition shall have the meaning ascribed to such terms in the Plan) and, in consideration of services to be rendered and as an incentive for the Holder’s best performance of
future services to Company and its Affiliates, to assign certain shares of Common Stock of the Company (hereinafter referred to as the “Performance-Based Restricted Shares”) to the Holder that will vest subject to his continued
employment and the attainment of certain performance goals, subject to the provisions set forth herein. 
 NOW, THEREFORE, in
consideration of the mutual covenants herein contained and other good and valuable consideration, receipt of which is hereby acknowledged, the parties hereto do hereby agree as follows: 

ARTICLE I. 
 AWARD OF
PERFORMANCE SHARES 
 Section 1.1 Award of Performance Shares. 

In consideration of Holder’s services and for other good and valuable consideration which the Committee has determined is sufficient, the
Company hereby awards and assigns to the Holder, on the Grant Date, 30,000 Performance-Based Restricted Shares (this “Award”). The Performance-Based Restricted Shares are awarded under and subject to the terms and conditions of the Plan.

 Section 1.2 Not a Contract of Employment. 

Nothing in this Agreement shall confer upon the Holder any right to continue in the employ or service of the Company or any Affiliate, or
shall interfere with or restrict in any way any otherwise existing rights of the Company and any Affiliate, which are hereby expressly reserved, to discharge the Holder at any time for any reason whatsoever, with or without Cause. 

Section 1.3 Covenants. 

In the event Holder breaches any restrictive covenants to which Holder is bound (including, without limitation, the Restrictive Covenant
Agreements, as such term is defined in Holder’s Letter Agreement with the Company dated as of November 2, 2016, the “Employment Agreement”)), in addition to any other remedy available to the Company, any
Performance-

 
Based Restricted Shares will be immediately forfeited without any notice or consideration being paid therefor and the Company shall be entitled to recoup income realized upon the prior vesting of
any Performance-Based Restricted Shares granted hereunder. By signing below, Holder acknowledges that the grant of Performance-Based Restricted Shares hereunder is additional consideration for the representations and covenants set forth in the
Restrictive Covenant Agreements. In addition, Holder acknowledges that Holder has read the covenants contained in the Restrictive Covenant Agreements and has had an opportunity to consult with an attorney of Holder’s own choice (at
Holder’s expense) prior to signing and understands that signing this Agreement is a condition to any rights Holder may have under this Agreement. 

ARTICLE II. 

RESTRICTIONS 

Section 2.1 Definition. 

“Performance Criteria” shall mean those confidential performance goals established by the Committee and separately
communicated to the Holder in writing. 
 “Performance Period” shall mean the period from January 1, 2016 through
December 31, 2019. 
 “Pro Rata Portion” shall mean that percentage of this Award calculated as follows: the number of
days from January 1, 2016 through the date of termination as a result of death or Disability divided by 1460. 

“Restrictions” shall mean the restrictions on sale or other transfer set forth in Section 3.1, the exposure to
forfeiture set forth in Section 2.2 and the vesting set forth in Section 2.3. 
 Section 2.2 Forfeiture –
Vesting-Based on Continued Employment. 
 (a) The Performance-Based Restricted Shares shall be forfeited in full without payment upon
the termination of employment of the Holder for any reason prior to December 31, 2019 other than as a result of the Holder’s death or Disability, or as provided in the Section 5(b) of the Employment Agreement on or following a Change of
Control. 
 (b) In the event of the termination of the Holder’s employment as a result of the death or Disability of the Holder,
notwithstanding anything that may be to the contrary contained in the Plan, Performance-Based Restricted Shares shall be deemed vested with respect to a Pro Rata Portion of this Award based on the actual achievement of the Performance Criteria;
provided that the Performance Period shall be deemed to have ended on the last day of the fiscal year in which the date of death occurs and the Committee shall determine in its sole discretion the extent to which the Performance Criteria has been
attained and such determination shall be final and binding on the Holder. Any remaining unvested portion of this Award shall be forfeited at the time of such determination. 

(c) This Award shall be deemed vested for purposes of this Section 2.2 if the Holder’s employment is terminated by the Company
without Cause on or following a Change of 

  
 2 

 
Control, by the Holder for Good Reason on or following a Change of Control or by the Holder without Good Reason following one year after a Change of Control, pursuant and subject to the
provisions and conditions of Section 5(b) of the Employment Agreement. 
 Section 2.3 Vesting and Lapse of Restrictions-
Attainment of Performance Criteria. 
 (a) Subject to Sections 2.2, 2.4 and 2.6, each Performance-Based Restricted Share shall not be
transferable or earned until such share becomes vested. The Performance-Based Restricted Shares shall vest and the Restrictions on such shares shall lapse with respect to that number of Performance-Based Restricted Shares based on the
Committee’s determination of the extent to which the Performance Criteria has been attained and such determination shall be final and binding on the Holder. 

(b) The Committee shall determine whether the Performance Criteria has been attained and the number of Performance-Based Restricted Shares, if
any, earned by the Holder for the Performance Period within forty-five (45) days following the Company’s filing of its audited financials for the fiscal year ending December 31, 2019 (the “Determination Date”);
provided, however, that if the Determination Date shall fall on a date which is during a black-out period with respect to the Common Stock to which Holder is subject, such date shall be delayed
until the first day after the expiration of such black-out period. Any portion of Performance-Based Restricted Shares that do not vest pursuant to the Committee’s determination of the attainment of the
Performance Criteria shall be forfeited without any payment. 
 (c) Upon a Change of Control occurring on or prior to the Determination
Date, the Performance Criteria shall be deemed to have been satisfied in full. For the sake of clarity, in the event of a Change of Control, the employment conditions specified in Section 2.2 shall continue to apply and this Award shall be
deemed vested upon the satisfaction of the employment conditions as provided in Section 2.2. 
 Section 2.4 Legend.

 Certificates representing Performance-Based Restricted Shares assigned pursuant to this Agreement shall, until all Restrictions lapse or
shall have been removed and new certificates are assigned pursuant to Section 2.5, be held by the Company and bear the following legend: 

“THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO CERTAIN VESTING REQUIREMENTS UNDER THE TERMS OF THAT CERTAIN
PERFORMANCE-BASED RESTRICTED STOCK AWARD AGREEMENT BY AND BETWEEN WEBMD HEALTH CORP. (THE “COMPANY”) AND THE REGISTERED OWNER OF SUCH SHARES, AND SUCH SHARES MAY NOT BE, DIRECTLY OR INDIRECTLY, OFFERED, TRANSFERRED, SOLD, ASSIGNED,
PLEDGED, HYPOTHECATED OR OTHERWISE DISPOSED OF UNDER ANY CIRCUMSTANCES, EXCEPT PURSUANT TO THE PROVISIONS OF SUCH AGREEMENT.” 

  
 3 

 Section 2.5 Assignment of Certificates for Vested Shares. 

Upon the vesting of all or a portion of the Performance-Based Restricted Shares as provided in Sections 2.2 and 2.3 and subject to
Section 3.3, the Company shall cause new certificates to be assigned with respect to that number of such vested shares and delivered to the Holder or Holder’s legal representative, free from any Restrictions and free from the legend
provided for in Section 2.4; provided, that such shares shall remain subject to applicable securities laws and the Company’s employee trading policy. Such vested shares shall be considered shares of Common Stock of the Company free
of all Restrictions (other than any applicable securities law restrictions or any restrictions imposed by the Company’s employee trading policy). 

Section 2.6 Restrictions On New Shares. 

In the event that the Holder receives any new or additional or different shares or securities by reason of any transaction or event described
in Section 15.1 of the Plan, such new or additional or different shares or securities which are attributable to the Holder in Holder’s capacity as the registered owner of the Performance-Based Restricted Shares then subject to
Restrictions, shall be considered to be Performance-Based Restricted Shares and shall be subject to all of the Restrictions, unless the Committee provides, for the removal or lapse of the Restrictions on the Performance-Based Restricted Shares
underlying the distribution of the new or additional shares or securities. 
 ARTICLE III. 

MISCELLANEOUS 

Section 3.1 Performance-Based Restricted Shares Not Transferable. 

No Performance-Based Restricted Shares or any interest or right therein or part thereof shall be liable for the debts, contracts or
engagements of the Holder or Holder’s successors in interest or shall be subject to disposition by transfer, alienation, anticipation, pledge, encumbrance, assignment or any other means whether such disposition be voluntary or involuntary or by
operation of law by judgment, levy, attachment, garnishment or any other legal or equitable proceedings (including bankruptcy), and any attempted disposition thereof shall be null and void and of no effect. 

Section 3.2 Conditions to Delivery of Stock Certificates. 

The Company shall not be required to deliver any certificate or certificates for shares of stock pursuant to this Agreement prior to
fulfillment of all of the following conditions: 
 (a) The obtaining of any approval or other clearance from any state or federal
governmental agency which the Committee shall, in its sole discretion, determine to be necessary or advisable; and 
 (b) The payment by the
Holder of all amounts required to be withheld, under federal, state and local (or applicable foreign) tax laws, with respect to the issuance and/or the lapse or removal of any of the Restrictions which may be paid either by the Holder or by the

  
 4 

 
Company withholding that number of shares of Common Stock with a Fair Market Value equal to the minimum tax withholding obligation in accordance with procedures established by the Company; and

 (c) The lapse of such reasonable period of time as the Committee may from time to time establish for reasons of administrative
convenience. 
 In addition, the Company may, at its sole election, cancel the Common Stock underlying the Performance-Based Restricted
Shares in the event the Holder fails to satisfy the applicable tax withholdings within 45 days of the applicable vesting date. 

Section 3.3 Physical Custody. 

The Secretary of the Company or such other representative as the Committee may appoint shall retain physical custody of each certificate
representing Performance-Based Restricted Shares until all of the Restrictions imposed under this Agreement with respect to the shares evidenced by such certificate expire or shall have been removed; provided, however, that in no event
shall the Holder retain physical custody of any certificates representing unvested Performance-Based Restricted Shares assigned to Holder. 

Section 3.4 Notices. 

Any notice required by this Agreement will be deemed provided and delivered to the intended recipient when (i) delivered in person by
hand or, in accordance with applicable law, via the Company’s e-mail or intranet site; or (ii) three days after being sent via U.S. certified mail, return receipt requested; or (iii) the day
after being sent via overnight courier, in each case provided such notice is properly addressed to the following address and enclosed in a properly sealed envelope or wrapper, and with all postage and similar fees having been paid in advance. 

 

			
	If to the Company:	  	 WebMD Health Corp.
 395 Hudson Street – 3rd Floor
 New York, NY 10014

		
	And if to the Holder:	  	To the address specified in the Company’s payroll records.

 By a notice given pursuant to this Section 3.4, either party may hereafter designate a different address
for notices to be given. Any notice which is required to be given to the Holder shall, if the Holder is then deceased, be given to the Holder’s personal representative if such representative has previously informed the Company of
representative’s status and address by written notice under this Section 3.4. 
 Section 3.5 Rights as
Stockholder. 
 Except as otherwise provided herein, upon delivery of the Performance-Based Restricted Shares to the representative
pursuant to Section 3.3, the Holder shall have, unless otherwise provided by the Committee, all the rights of a stockholder with respect to said shares, including the right to vote and the right to receive all dividends and other distributions
paid or made with respect to the shares; provided, however, that any dividends or extraordinary 

  
 5 

 
distributions with respect to the Performance-Based Restricted Shares shall be subject to the same Restrictions that apply to the corresponding Performance-Based Restricted Shares and such
Restrictions will only lapse if, and to the extent that, the Restrictions on the corresponding Performance-Based Restricted Shares lapse. 

Section 3.6 Withholding Tax. 

The Holder agrees that, in the event of the issuance of the Performance-Based Restricted Shares or the expiration of Restrictions thereon
results in the Holder’s realization of income which for federal, state or local income tax purposes is, in the opinion for the Company, subject to withholding of tax at source by the Company, the Holder will pay to the Company an amount equal
to such withholding tax prior to the Company’s delivery of the Certificate or the Company shall withhold that number of Shares of Common Stock with a Fair Market Value equal to the minimum tax withholding obligation. 

Section 3.7 Titles. 

Titles are provided herein for convenience only and are not to serve as a basis for interpretation or construction of this Agreement. 

Section 3.8 Conformity to Securities Laws. 

The Holder acknowledges that this Agreement is intended to conform to the extent necessary with all provisions of all applicable federal and
state (and applicable foreign) laws, rules and regulations (including but not limited to, the 1933 Act and the 1934 Act) and to such approvals by any listing, regulatory or other governmental authority as may, in the opinion of counsel for the
Company, be necessary or advisable in connection therewith. Notwithstanding anything herein to the contrary, this Agreement shall be administered, and the Performance-Based Restricted Shares shall be assigned, only in such a manner as to conform to
such laws, rules and regulations including, without limitation, Rule 16b-3. To the extent permitted by applicable law, this Agreement and the Performance-Based Restricted Shares assigned hereunder shall be
deemed amended to the extent necessary to conform to such laws, rules and regulations. 
 Section 3.9 Amendment. 

This Agreement may be amended without the consent of the Holder provided that such amendment would not impair any rights of the Holder under
this Agreement. No amendment of this Agreement shall, without the consent of the Holder, impair any rights of the Holder under this Agreement. 

Section 3.10 Governing Law. 

The laws of the State of Delaware shall govern the interpretation, validity, administration, enforcement and performance of the terms of this
Agreement regardless of the law that might be applied under principles of conflicts of laws. 

  
 6 

 Section 3.11 Section 83(b) Election. 

If, within 30 days of the Grant Date, a Holder makes an election under Section 83(b) of the Code, or any successor section thereto, to be
taxed with respect to all or any portion of the Performance-Based Restricted Shares as of the date of transfer of the Performance Shares rather than as of the date or dates upon which the Holder would otherwise be taxable under Section 83(a) of the
Code, the Holder shall deliver a copy of such election to the Company immediately after filing such election with the Internal Revenue Service. 

Section 3.12 The Plan 
 The Plan is
incorporated in this Agreement by reference and together with this Agreement sets forth the terms and conditions of the Performance-Based Restricted Shares. In the event of any conflict or inconsistency between the Plan and this Agreement, the Plan
shall govern and this Agreement shall be interpreted to minimize or eliminate any such conflict or inconsistency. 
 IN WITNESS WHEREOF,
this Agreement has been executed and delivered by the parties hereto. 
  

			
	 WEBMD HEALTH CORP.,
 a Delaware
corporation

		
	By:	 	     /s/ Lewis H. Leicher

		 	Lewis H. Leicher
		
	Its:	 	 Senior Vice President

  

	
	HOLDER:
	
	     /s/ Steven L. Zatz

	Steven L. Zatz

  
 7EX-10.51

 Exhibit 10.51 

CONFORMED COPY 
  

									
		  		  		  	

	  	 111 Eighth Avenue
 New York, NY 10011

212.624.3700

 May 1, 2012 
 Richard
Treese 
 [address on file with Registrant] 
 Dear Rick,

 This letter will confirm the terms of your offer of employment with WebMD, LLC. and/or its subsidiaries (the “Company”), a subsidiary of WebMD
Health Corp. (“WebMD Health”). It is anticipated that your first day of employment with the Company will be May 29, 2012. Such terms are as follows: 
  

	1.	Position and Responsibilities. You will serve in the position of Vice President, Consumer Technology1 and assume and discharge such responsibilities as are
commensurate with such position as your manager may direct. During your employment with the Company, you shall devote your full-time attention to your duties and responsibilities and shall perform them faithfully, diligently and completely. In
addition, you shall comply with and be bound by the operating policies, procedures and practices of the Company including, without limitation, the Code of Conduct, in effect from time to time during your employment. You acknowledge that you shall be
required to travel in connection with the performance of your duties. 

 2. Compensation. 

 

	 	a)	In consideration of your services, you will be paid an annual base salary of $250,000.002 at a bi-weekly rate of $9,615,
subject to applicable tax withholdings and ordinary deductions. Pursuant to the Company’s regular payroll practices at your time of hire, you will be paid bi-weekly, on every other Friday. As an exempt
employee, you are not eligible to receive overtime pay. 

  

	 	b)	You will be eligible to participate in the WebMD annual bonus plan starting in 2012. The amount of any such bonus will be determined at the Company’s sole discretion, considering both individual and Company
performance, and will be paid in accordance with the Company’s bonus distribution schedule, so long as you are employed on the payment date. Your current annual bonus target is 40% of your annual base salary,
pro-rated for 2012 based on your hire date. The Company reserves the right to modify the manner or mode of compensating employees for performance in a performance year. 

 

	 	c)	Sign-On Payment: You will receive a one-time payment of $30,000, minus applicable tax withholding, to be paid after your 30th day of employment (on or about June 29, 2012), provided you are in good standing at the time. Should you resign your position within 24 months from your date of hire, the payment shall be
considered recoverable on a pro-rated basis from your date of hire. 

  

	3.	Other Benefits. You will be entitled to receive the standard employee benefits made available by the Company to its employees to the full extent of your eligibility. You shall be entitled to 20 paid

  
  

	1 	Effective January 13, 2017, the Board of Directors of WebMD appointed Mr. Treese to the position of Executive Vice President & Chief Technology Officer of
WebMD. 

  

	2 	 Effective January 13, 2017, the Compensation Committee of the Board of Directors of WebMD
set Mr. Treese’s annual base salary at $380,000.00. 

	 	
vacation days per year with your first year accrual pro-rated based on your start date. During your employment, you shall be permitted, to the extent
eligible, to participate in any group medical, dental, life insurance and disability insurance plans, or similar benefit plan of the Company that is available to employees generally. Participation in any such plan shall be consistent with your rate
of compensation to the extent that compensation is a determinative factor with respect to coverage under any such plan. You have 31 days from your date of hire to complete the benefits enrollment process as indicated in your new hire packet.
Benefits eligibility begins on the first day of the month following the first day of your employment with the Company (this excludes short-term disability insurance which begins 90 days after the first day of your employment). The Company shall
reimburse you for all reasonable expenses actually incurred or paid by you in the performance of your services on behalf of the Company, upon prior authorization and approval in accordance with the Company’s expense reimbursement policy as from
time to time in effect. 

  

	4.	Stock Options. Subject to the approval of the Compensation Committee of the Board of Directors of WebMD Health and under the terms and conditions of the WebMD Health Corp. Amended and Restated 2005 Long Term
Incentive Plan (the “Equity Plan”), including the vesting provisions contained therein, you will be granted on your first day of employment (the “Date of Grant”) a non-qualified option (the
“Option”) to purchase 10,000 shares of common stock of WebMD Health. The exercise price of the Option will be the closing price of the common stock on the Date of Grant. The Option will have a term of ten (10) years, subject
to earlier termination in the event of the termination of your employment. The Option shall vest and become exercisable, subject to your continued employment on the applicable dates, as follows: 25% of the Option on each of the first, second,
third and fourth anniversaries of the Date of Grant (full vesting occurring on the fourth anniversary of the Date of Grant). The Option shall be evidenced by and subject to the terms of the Company’s standard form stock option agreement, which
will be sent to you separately. 

  

	5.	Restricted Stock. Subject to the approval of the Compensation Committee and under the terms of the Equity Plan and a restricted stock agreement to be entered into between you and WebMD Health (which shall be the
standard agreement for executives of the Company), you shall be granted on the first day of your employment, 4,000 shares of restricted stock of WebMD Health. The shares shall vest and the restrictions thereon lapse in equal annual installments of
25% over four years, commencing on the first anniversary of the date of grant subject to your continued employment on the applicable dates 

  

	6.	Restrictive Covenants. You agree that your employment is contingent upon your execution of, and delivery to the Company of a Restrictive Covenants Agreement in the form attached hereto as Annex A.

  

	7.	Conflicting Employment. You agree that, during your employment with the Company, you will not engage in any other employment, occupation, consulting or other business activity directly related to the business in
which the Company is now involved or becomes involved during your employment, nor will you engage in any other activities that conflict with your obligations to the Company. 

 

	8.	At-Will Employment. You acknowledge that your employment with the Company is for an unspecified duration that constitutes at-will
employment, and that either you or the Company can terminate this relationship at any time, with or without cause and with or without notice. 

  
 2 

	9.	Prior Employment. You represent that you have delivered to the Company an accurate and complete copy of any and all agreements with any prior employer to which you continue to be subject. You represent that the
execution by you of this offer letter and the performance by you of your obligations hereunder shall not conflict with, or result in a violation or breach of, any other agreement or arrangement, including, without limitation any employment,
consulting or confidentiality/non-competition/non-solicitation agreement. You hereby agree to abide by the limitations on your conduct as set forth in any agreement
between you and your prior employer. In your work for the Company, you will be expected not to use or disclose any confidential information, including trade secrets, of any former employer or other person to whom you have an obligation of
confidentiality. Rather, you will be expected to use only that information which is generally known and used by persons with training and experience comparable to your own, which is common knowledge in the industry or otherwise legally in the public
domain, or which is otherwise provided or developed by the Company. During our discussions about your proposed job duties, you assured us that you would be able to perform those duties within the guidelines just described. 

You agree you will not bring onto Company premises any unpublished documents or property belonging to any former employer or other person to
whom you have any obligation of confidentiality. 
  

	10.	General Provisions. 

  

	 	(a)	Your employment is contingent upon successful completion of a background check (including employment, education, criminal history, references and debarred parties). We would caution you not to resign any current
employment until you have received notification of successful completion of both. 

  

	 	(b)	We are required by law to confirm your eligibility for employment in the United States. Thus, you will be asked to provide proof of your identity and eligibility to work in the U.S. on your start date.

  

	 	(c)	This offer letter (including Annex A) and the terms of your employment will be governed by the laws of New York, applicable to agreements made and to be performed entirely within such state. 

 

	 	(d)	This offer letter sets forth the entire agreement and understanding between the Company and you relating to your offer of employment and supersedes all prior verbal discussions between us. 

 

	 	(e)	This offer letter will be binding upon your heirs, executors, administrators and other legal representatives and will be for the benefit of the Company and its respective successors and assigns. 

 

	 	(f)	All payments pursuant to this offer letter will be subject to applicable withholding taxes. 

  
 3 

 Please acknowledge and confirm your acceptance of this offer letter, including Annex A, by signing and returning
one copy of this offer letter and Annex A) in their entirety to Kathleen Tourjee at 646-674-6941, no later than May 7, 2012. Your new hire packet will provide you
with further instructions for additional required paperwork. We look forward to a mutually rewarding working arrangement. 
  

			
	 By
	 	   /s/ Raymond C. Flack

		 	Raymond C. Flack
		 	Director, Recruiting

 OFFER ACCEPTANCE: 
 I
understand and accept the terms of my employment with WebMD, LLC as set forth herein. I understand that this offer letter does not constitute a contract of employment for any specified period of time, and that either party, with or without cause and
with or without notice, may terminate my employment relationship. I specifically acknowledge that I have been given notice of my rate of pay and the Company’s regular pay days, as set forth in paragraph 2(a) above. I know to direct any
questions regarding my pay to my manager or Human Resources. 
  

					
	   /s/ Richard Treese
	  	    Date: 5/1/12	  	
	Richard Treese	  		  	

  
 4 

 ANNEX A 

RESTRICTIVE COVENANT AGREEMENT 
 In
consideration of my employment with WebMD LLC and/or any of its corporate parents, subsidiaries, divisions, or affiliates, or the successors or assigns of any of the foregoing (hereinafter referred to as the “Company”), I hereby agree as
follows: 
  

	1.	Confidentiality. 

  

	 	a)	Trade Secret and Proprietary Information. I understand and acknowledge that, during the course of my employment with the Company and as a result of my having executed this Restrictive Covenant Agreement
(“Agreement”), I will be granted access to valuable information relating to the business of the Company that provides the Company with a competitive advantage (or that could be used to the disadvantage of the Company by a Competitive
Business) (as defined herein), which is not generally known by, nor easily learned or determined by, persons outside the Company (collectively “Trade Secret and Proprietary Information”). The term “Trade Secret and Proprietary
Information” shall include, but shall not be limited to: (a) specifications, manuals, software in various stages of development; (b) customer and prospect lists, and details of agreements and communications with customers and
prospects; (c) sales plans and projections, product pricing information, acquisition, expansion, marketing, financial and other business information and existing and future products and business plans of the Company; (d) sales proposals,
demonstrations systems, sales material; (e) research and development; (f) computer programs; (g) sources of supply; (h) identity of specialized consultants and contractors and Trade Secret and Proprietary Information developed by
them for the Company; (i) purchasing, operating and other cost data; (j) special customer needs, cost and pricing data; (k) employee information (including, but not limited to, personnel, payroll, compensation and benefit data and
plans); and (l) patient information, including without limitation Protected Health Information as defined in 45 C.F.R. 164.50, including all such information recorded in manuals, memoranda, projections, reports, minutes, plans, drawings,
sketches, designs, formula books, data, specifications, software programs and records, whether or not legended or otherwise identified by the Company as Trade Secret and Proprietary Information, as well as such information that is the subject of
meetings and discussions and not recorded. Trade Secret and Proprietary Information shall not include such information that I can demonstrate (i) is generally available to the public (other than as a result of a disclosure by me), (ii) was
disclosed to me by a third party under no obligation to keep such information confidential or (iii) was known by me prior to, and not as a result of, my employment or anticipated employment with the Company. 

 

	 	b)	Duty of Confidentiality. I agree at all times, both during and after my employment with the Company, to hold all of the Trade Secret and Proprietary Information in a fiduciary capacity for the benefit of the
Company and to safeguard all such Trade Secret and Proprietary Information. I also agree that I will not directly or indirectly disclose or use any such Trade Secret and Proprietary Information to any third person or entity outside the Company,
except as may be necessary in the good faith performance of my duties for the Company. I further agree that, in addition to enforcing this restriction, the Company may have other rights and remedies under the common law or applicable statutory
laws relating to the protection of trade secrets. Notwithstanding anything in this Agreement to the contrary, I understand that I may disclose the Trade Secret and Proprietary Information to the extent required by applicable laws or
governmental regulations or judicial or regulatory process, provided that I give the Company prompt notice of any and all such requests for disclosure so that it has ample opportunity to take all necessary or desired action, to avoid disclosure.

	 	c)	Company Property. I acknowledge that: (i) all Trade Secret and Proprietary Information of the Company, (ii) computers, and computer-related hardware and software, cell phones, beepers and any other
equipment provided to me by the Company, and (iii) all documents I create or receive in connection with my employment with the Company, belong to the Company, and not to me personally (collectively, “Company Property”). Such
documents include, without limitation and by way of non-exhaustive example only: papers, files, memoranda, notes, correspondence, lists, e-mails, reports, records, data,
research, proposals, specifications, models, flow charts, schematics, tapes, printouts, designs, graphics, drawings, photographs, abstracts, summaries, charts, graphs, notebooks, investor lists, customer/client lists, and all other compilations
of information, regardless of how such information may be recorded and whether in printed form or on a computer or magnetic disk or in any other medium. I agree to return all Company Property (including all copies) to the Company immediately
upon any termination of my employment, and further agree that, during and after my employment with the Company, I will not, under any circumstances, without the Company’s specific written authorization in each instance, directly or indirectly
disclose Company Property or any information contained in Company Property to anyone outside the Company, or otherwise use Company Property for any purpose other than the advancement of the Company’s interests. 

 

	 	d)	Unfair Competition. I acknowledge that the Company has a compelling business interest in preventing unfair competition stemming from the intentional or inadvertent use or disclosure of the Company’s
Trade Secret and Proprietary Information and Company Property. 

  

	 	e)	Investors, Other Third-Parties, and Goodwill. I acknowledge that all third-parties (e.g., customers, vendors, and advertisers) I service or propose to service while employed by the Company are doing business
with the Company and not me personally, and that, in the course of dealing with such third-parties, the Company establishes goodwill with respect to each such third-party that is created and maintained at the Company’s expense
(“Third-Party Goodwill”). I also acknowledge that, by virtue of my employment with the Company, I have gained or will gain knowledge of the business needs of, and other information concerning, third-parties, and that if such
information were used to solicit or service any such third-parties on my own behalf or on behalf of a Competitive Business (as defined herein), the Company would be competitively disadvantaged. 

 

	 	f)	 Intellectual Property and Inventions. I acknowledge that all developments, including, without
limitation, the creation of new products, conferences, training/seminars, publications, programs, methods of organizing information, inventions, discoveries, concepts, ideas, improvements, patents, trademarks, trade names, copyrights, trade secrets,
designs, works, reports, computer software, flow charts, diagrams, procedures, data, documentation, and writings and applications thereof relating to the past, present, or future business of the Company that I, alone or jointly with others, may have
discovered, conceived, created, made, developed, reduced to practice, or acquired during my employment with the Company (collectively, “Developments”) are works made for hire and shall remain the sole and exclusive property of the Company,
and I hereby assign to the Company all of my rights, titles, and interest in and to all such Developments, if any. I agree to disclose to the Company promptly and fully all future Developments and, at any

  
 2 

	 	
time upon request and at the expense of the Company, to execute, acknowledge, and deliver to the Company all instruments that the Company shall prepare, to give evidence, and to take any and all
other actions that are necessary or desirable in the reasonable opinion of the Company to enable the Company to file and prosecute applications for, and to acquire, maintain, and enforce, all letters patent, trademark registrations, or copyrights
covering the Developments in all countries in which the same are deemed necessary by the Company. All data, memoranda, notes, lists, drawings, records, files, investor and client/customer lists, supplier lists, and other documentation (and all
copies thereof) made or compiled by me or made available to me concerning the Developments or otherwise concerning the past, present, or planned business of the Company are Company Property, and will be delivered to the Company immediately upon the
termination of my employment with the Company. 

  

	2.	Covenant Not to Compete with the Company. 

  

	 	a)	I acknowledge that the business of the Company can be conducted anywhere in the world and is not limited to a geographic scope or region, that its products, programs and services are marketed throughout the United
States, Canada and other geographic regions throughout the world, that the Company competes in nearly all of its business activities with other individuals or entities that are, or could be, located in nearly any part of the world and that the
nature of my services, position, and expertise are such that I am capable of competing with the Company from nearly any location in the world. 

  

	 	b)	Accordingly, in order to protect the Company’s Trade Secret and Proprietary Information and Third-Party Goodwill, I acknowledge and agree that during my employment with the Company and for a period of one year after the date my employment with the Company is terminated for any reason (the “Restricted Period”), I will not, without the Company’s express written permission, directly or
indirectly (including through the Internet), own, control, manage, operate, participate in, be employed by, or act for or on behalf of (as principal, agent, employee, consultant, director or otherwise), any “Competitive Business” (as
defined herein) located anywhere within the geographic boundaries of the United States, Canada and the world. 

  

	 	c)	For purposes of this Agreement “Competitive Business” will mean: (i) any enterprise engaged in developing, selling or providing (via the internet or other means) health or wellness information, decision
support tools or services or applications and/or communication services, directly or indirectly, to consumers, health and/or benefit plan members or employees or healthcare professionals, including but not limited to products or services that
provide information on diseases, conditions or treatments, store health care information, assess personal health status, and/or assist in making informed benefit, provider or treatment choices; and (ii) any enterprise engaged in any other type
of business in which the Company is also engaged, or plans to be engaged, so long as I am directly involved in such business or planned business on behalf of the Company. Notwithstanding the foregoing, I understand that I may have an interest
consisting of publicly traded securities constituting less than 1 percent of any class of publicly traded securities in any public company engaged in a Competitive Business, so long as I am not employed by, do not consult with, or become a
director of or otherwise engage in any activities for, such company. 

  
 3 

	3.	Non-Solicitation of Employees, Customers. In order to protect the Company’s Trade Secret and Proprietary Information and Third-Party Goodwill, during the
Restricted Period, I will not, without the Company’s express written permission, directly or indirectly: 

  

	 	a)	solicit, induce, hire, engage, or attempt to hire or engage any employee or independent contractor of the Company, or in any other way interfere with the Company’s employment or contractual relations with any
of its employees or independent contractors, nor will I solicit, induce, hire, engage or attempt to hire or engage any individual who was an employee of the Company at any time during the one (1) year period immediately prior to the termination
of my employment with the Company; and 

  

	 	b)	contact, call upon, encourage or solicit, on behalf of a Competitive Business, any existing or prospective client, or customer of the Company who I serviced, or otherwise developed a relationship with, or about whom I
obtained confidential information as a result of my employment with the Company, nor will I attempt to divert or take away from the Company the business of any such client or customer. 

 

	4.	Injunctive Remedies. I acknowledge and agree that the restrictions contained in this Agreement are reasonably necessary to protect the legitimate business interests of the Company, and that any violation of
any of the restrictions will result in immediate and irreparable injury to the Company for which monetary damages will not be an adequate remedy. I further acknowledge and agree that if any such restriction is violated, the Company will be
entitled to immediate relief enjoining such violation (including, without limitation, temporary and permanent injunctions, a decree for specific performance, and an equitable accounting of earnings, profits, and other benefits arising from such
violation) in any court having jurisdiction over such claim, without the necessity of showing any actual damage or posting any bond or furnishing any other security, and that the specific enforcement of the provisions of this Agreement will not
diminish my ability to earn a livelihood or create or impose upon me any undue hardship. I also agree that any request for such relief by the Company shall be in addition to, and without prejudice to, any claim for monetary damages that the
Company may elect to assert. In addition, the Restricted Period shall be extended for a period of time equal to the period of time during which I breached the restrictions contained herein. 

 

	5.	Severability Provision. I acknowledge and agree that the restrictions imposed upon me by the terms, conditions, and provisions of this Agreement are fair, reasonable, and reasonably required for the
protection of the Company. In the event that any part of this Agreement is deemed invalid, illegal, or unenforceable, all other terms, conditions, and provisions of this Agreement shall nevertheless remain in full force and effect. In the
event that the provisions of any of Sections 1, 2, or 3 of this Agreement relating to the geographic area of restriction, the length of restriction or the scope of restriction shall be deemed to exceed the maximum area, length or scope that a court
of competent jurisdiction would deem enforceable, said area, length or scope shall, for purposes of this Agreement, be deemed to be the maximum area, length of time or scope that such court would deem valid and enforceable, and that such court has
the authority under this Agreement to rewrite (or “blue-pencil”) the restriction(s) at-issue to achieve this intent. 

 

	6.	Non-Waiver. Any waiver by the Company of my breach of any term, condition, or provision of this Agreement shall not operate or be construed as a waiver of the
Company’s rights upon any subsequent breach. 

  
 4 

	7.	Waiver of Jury Trial. TO THE MAXIMUM EXTENT PERMITTED BY LAW, I HEREBY KNOWINGLY, VOLUNTARILY, AND INTENTIONALLY WAIVE THE RIGHT TO A TRIAL BY JURY IN CONNECTION WITH ANY LITIGATION ARISING OUT OF, UNDER,
IN CONNECTION WITH, OR IN ANY WAY RELATED TO THIS AGREEMENT. THIS INCLUDES, WITHOUT LIMITATION, ANY LITIGATION CONCERNING ANY COURSE OF CONDUCT, COURSE OF DEALING, STATEMENT (WHETHER VERBAL OR WRITTEN), OR ACTION OF THE COMPANY OR
ME, OR ANY EXERCISE BY THE COMPANY OR ME OF OUR RESPECTIVE RIGHTS UNDER THIS AGREEMENT OR IN ANY WAY RELATING TO THIS AGREEMENT. I FURTHER ACKNOWLEDGE THAT THIS WAIVER IS A MATERIAL INDUCEMENT FOR THE COMPANY TO ISSUE AND ACCEPT
THIS AGREEMENT. 

  

	8.	Notice to Future Employers. For a period of two (2) years after my employment with the Company ends, I will inform each new employer, prior to accepting employment, of the existence and details of the
covenants contained in this Annex A and will provide each such employer with a copy of this Annex. 

  

	9.	Assignment. The Company shall have the right to assign its rights and obligations under this Annex A without my consent. I acknowledge that I may not assign my obligations herein. 

RESTRICTIVE COVENANT AGREEMENT ACCEPTANCE 
 I understand
and accept the restrictions and obligations imposed upon me by the terms, conditions, and provisions set forth in this Restrictive Covenant Agreement and agree to abide by same. 

 

			
	   /s/ Richard Treese
	  	Date: 5/1/12
	Richard Treese	  	

  
 5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00267-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00267-of-00352.parquet"}]]